Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,515 | 235 | 84.6% |
| Travel and Lodging | $786.71 | 2 | 14.7% |
| Entertainment | $31.52 | 2 | 0.6% |
| Education | $6.25 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,223 | 16 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $518.40 | 33 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $472.36 | 30 | $0 (2023) |
| Abbott Laboratories | $435.89 | 15 | $0 (2024) |
| PFIZER INC. | $381.62 | 21 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $228.75 | 14 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $221.82 | 12 | $0 (2024) |
| CARDIVA MEDICAL, INC. | $158.79 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $155.00 | 12 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $137.23 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $596.63 | 29 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($163.62) |
| 2023 | $882.66 | 45 | Abbott Laboratories ($202.54) |
| 2022 | $682.38 | 35 | Biosense Webster, Inc. ($96.81) |
| 2021 | $356.17 | 20 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($61.18) |
| 2020 | $75.67 | 5 | PFIZER INC. ($18.94) |
| 2019 | $583.72 | 29 | Abbott Laboratories ($139.63) |
| 2018 | $1,624 | 42 | BOSTON SCIENTIFIC CORPORATION ($1,079) |
| 2017 | $538.34 | 35 | Janssen Pharmaceuticals, Inc ($135.28) |
All Payment Transactions
240 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $47.70 | General |
| Category: Peripheral Intervention | ||||||
| 12/20/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $3.18 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.55 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/11/2024 | Abbott Laboratories | PERCLOSE PROSTYLE (Device) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Vascular | ||||||
| 12/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Obesity | ||||||
| 11/18/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Genetic Disease | ||||||
| 11/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.72 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/28/2024 | CARDIVA MEDICAL, INC. | SAVVYWIRE (Device) | Food and Beverage | In-kind items and services | $40.10 | General |
| Category: DEVICES | ||||||
| 10/18/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/14/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Genetic Disease | ||||||
| 09/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Cardiology | ||||||
| 09/11/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $18.18 | General |
| Category: Coronary | ||||||
| 08/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.69 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/01/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.46 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/31/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Transcatheter Heart Valves | ||||||
| 07/24/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $1.64 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/22/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/19/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/12/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Genetic Disease | ||||||
| 06/07/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.83 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/04/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Transcatheter Valve Systems | ||||||
| 05/22/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $36.67 | General |
| Category: Cardiology | ||||||
| 04/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.21 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/07/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 47 | 4,130 | 9,296 | $1.4M | $463,894 |
| 2022 | 51 | 4,268 | 7,949 | $1.3M | $462,371 |
| 2021 | 52 | 4,390 | 7,495 | $1.3M | $450,096 |
| 2020 | 50 | 3,949 | 7,739 | $1.2M | $412,910 |
All Medicare Procedures & Services
200 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 184 | 1,335 | $113,475 | $61,748 | 54.4% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 54 | 54 | $125,010 | $39,978 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 392 | 432 | $90,720 | $39,372 | 43.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 123 | 771 | $100,230 | $29,247 | 29.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 175 | 191 | $68,760 | $25,886 | 37.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 470 | 1,569 | $117,480 | $24,778 | 21.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 151 | 169 | $48,165 | $22,764 | 47.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 153 | 370 | $46,250 | $22,660 | 49.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 98 | 217 | $38,626 | $20,096 | 52.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 290 | 975 | $78,000 | $19,958 | 25.6% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 26 | 26 | $44,200 | $15,807 | 35.8% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 39 | 39 | $42,120 | $15,639 | 37.1% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 183 | 607 | $84,980 | $15,348 | 18.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 103 | 326 | $35,860 | $12,584 | 35.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 64 | 64 | $26,280 | $10,581 | 40.3% |
| 93657 | Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | Facility | 2023 | 32 | 40 | $44,000 | $9,599 | 21.8% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2023 | 13 | 13 | $24,505 | $9,135 | 37.3% |
| 93655 | Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | Facility | 2023 | 26 | 27 | $23,760 | $6,479 | 27.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 85 | 177 | $14,160 | $6,412 | 45.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 98 | 99 | $14,850 | $5,827 | 39.2% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 166 | 196 | $18,090 | $5,407 | 29.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 434 | 520 | $33,800 | $5,374 | 15.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $13,230 | $5,323 | 40.2% |
| 33228 | Removal and replacement of dual lead permanent pacemaker | Facility | 2023 | 14 | 14 | $10,220 | $3,756 | 36.7% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 29 | 156 | $5,460 | $3,672 | 67.3% |
About Dr. Daniel Schneider, MD
Dr. Daniel Schneider, MD is a Clinical Cardiac Electrophysiology healthcare provider based in Mechanicsville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1508071846.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Schneider, MD has received a total of $5,339 in payments from pharmaceutical and medical device companies, with $596.63 received in 2024. These payments were reported across 240 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($4,515).
As a Medicare-enrolled provider, Schneider has provided services to 16,737 Medicare beneficiaries, totaling 32,479 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 200 distinct procedure/service records.
Practice Information
- Specialty Clinical Cardiac Electrophysiology
- Location Mechanicsville, VA
- Active Since 05/11/2007
- Last Updated 04/29/2025
- Taxonomy Code 207RC0001X
- Entity Type Individual
- NPI Number 1508071846
Products in Payments
- WATCHMAN (Device) $991.26
- LifeVest (Device) $518.40
- XARELTO (Drug) $472.36
- ELIQUIS (Drug) $449.07
- MULTAQ (Drug) $152.35
- Ensite Cardiac Mapping System (Device) $139.63
- JOT DX (Device) $102.60
- Soundstar (Device) $96.81
- GENERAL THERAPIES (Device) $96.25
- AMPLATZER AMULET (Device) $92.23
- LEQVIO (Drug) $88.35
- Hillrom - Carnation Ambulatory Monitor (Device) $86.74
- PRALUENT (Drug) $76.40
- Advisa (Device) $76.03
- Repatha (Biological) $74.40
- ONPATTRO (Drug) $68.90
- VYNDAQEL (Drug) $61.67
- Cardiva VASCADE MVP VVCS 6-12F (Device) $59.58
- FUROSCIX (Drug) $59.05
- ECM Patch,Pouch (Device) $57.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.